αααααβααΎαTKPHF β’ OTCMKTS
add
Takeda Pharmaceutical Co Ltd
31.12$
2 αα»αααα, 5:20:00 PM ααααβααα -5 · USD · OTCMKTS · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
ααΆαβα αα»αααΌααααααααααΆαα
α»ααααααΈαα
α’αΆαααα·α
αα·αααΈαα»α
31.12$
α
ααααααα½αααααΆαα
α»αααααα
24.95$ - 32.13$
ααΎαβαα»αβααΈααααΆα
55.30Β αααΈααΆα USD
ααα ααα½αααΌαααααα
43.74Β ααΆαα
α’αα»ααΆα P/E
-
αα·αααααβααΆαααΆα
-
ααΆααααααΌαα
αααα
TYO
αααα»αβααααααΆαβ
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
| (JPY) | ααααΌ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌα | 1.19Β ααααΈααΆα | 4.16% |
α
αααΆαααααα·ααααα·ααΆα | 661.30Β αααΈααΆα | -7.52% |
α
αααΌααα»ααα | 103.64Β αααΈααΆα | 335.66% |
ααααΆααα
αααααα»ααα | 8.70 | 318.27% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | β | β |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | 182.70Β αααΈααΆα | -8.24% |
α’ααααΆαααααααααΆαααααα·αααααΆα | 22.51% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
| (JPY) | ααααΌ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 654.94Β αααΈααΆα | 32.54% |
ααααααααα»α | 15.41Β ααααΈααΆα | 2.00% |
ααΆαααα½ααα»αααααΌαααα»α | 7.76Β ααααΈααΆα | 1.00% |
ααΌαβααααα»α | 7.64Β ααααΈααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 1.58Β αααΈααΆα | β |
ααααααααααΉαααααα
| 0.01 | β |
ααα
ααααααΎαααααα | 2.16% | β |
ααα
ααααααΎααΎααα»α | 2.55% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
| (JPY) | ααααΌ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌααα»ααα | 103.64Β αααΈααΆα | 335.66% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | 373.25Β αααΈααΆα | -2.74% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | -229.80Β αααΈααΆα | -98.86% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | -192.45Β αααΈααΆα | 70.66% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | -26.55Β αααΈααΆα | 92.72% |
ααα αΌαααΆα
αααααΆααααααα | 28.34Β αααΈααΆα | -90.09% |
α’αααΈ
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. Wikipedia
ααΆααααααΎαα‘αΎα
12 αα·αα»ααΆ 1781
αααααβαααααΆα
αα»ααααα·α
47,455